DeepMed Research

Seoul National University Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 2003-01-01

Employees: 501

Market Cap: -

Website: https://www.snubh.org

Clinical Trials

Adjunctive Atropine During Ketamine Sedation

Phase 4

Completed

Conditions: Conscious Sedation

Interventions: Drug: Atropine

First Posted Date: 2009-02-03

Last Posted Date: 2012-08-06

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 140

Registration Number: NCT00834470

Locations: 🇰🇷
Seoul National University Bundang Hospital, Gyeonggi-do, Korea, Republic of

RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)

Phase 2

Completed

Conditions: Renal Cell Carcinoma

Interventions: Drug: RAD001

First Posted Date: 2009-01-28

Last Posted Date: 2022-11-09

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 49

Registration Number: NCT00830895

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide

Phase 4

Completed

Conditions: Chronic Renal Insufficiency
Coronary Angiography

Interventions: Drug: contrast agent (iopromide)
Drug: contrast agent (iodixanol)

First Posted Date: 2009-01-15

Last Posted Date: 2010-07-07

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 420

Registration Number: NCT00823628

Locations: 🇰🇷
Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

The Effect of Maximum Body Weight in Lifetime on the Development of Type 2 Diabetes

Completed

Conditions: Diabetes
Prediabetes

First Posted Date: 2009-01-01

Last Posted Date: 2013-10-25

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 3000

Registration Number: NCT00816608

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Bundang-gu, Korea, Republic of

Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 2

Terminated

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: docetaxel+CDDP
Drug: docetaxel+S-1

First Posted Date: 2008-12-09

Last Posted Date: 2011-07-26

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 96

Registration Number: NCT00805012

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Low Dose of Midazolam is Superior to Conventional Dose for Rapid Sequence Intubation in Emergency Department (ED)

Not Applicable

Completed

Conditions: Intubation

Interventions: Drug: Low dose midazolam

First Posted Date: 2008-11-02

Last Posted Date: 2011-07-26

Lead Sponsor: Seoul National University Hospital

Registration Number: NCT00783731

Locations: 🇰🇷
Seoul National University Bundang Hospital, Emergency room, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷
Boramae Medical Center, Seoul, Korea, Republic of

Effect of Pain Control on the Diagnosis of Acute Appendicitis on the Diagnostic Accuracy of General Surgeon

Phase 4

Completed

Conditions: Appendicitis

Interventions: Drug: Morphine

First Posted Date: 2008-10-31

Last Posted Date: 2011-07-26

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 234

Registration Number: NCT00783016

Locations: 🇰🇷
Seoul National University Bundang Hospital, Emergency room, Seongnam-si, Gyeonggi-do, Korea, Republic of

The Efficacy of CILostazol ON Ischemic Complications After DES Implantation

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: cilostazol

First Posted Date: 2008-10-21

Last Posted Date: 2013-12-17

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 960

Registration Number: NCT00776828

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy

Not Applicable

Completed

Conditions: Proliferative Diabetic Retinopathy
Vitreous Hemorrhage

Interventions: Drug: Bevacizumab

First Posted Date: 2008-09-03

Last Posted Date: 2015-12-21

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 126

Registration Number: NCT00745498

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyunggi-do, Korea, Republic of

Effect of Antioxidant on Endurance Performance in Healthy Men

Phase 2

Completed

Conditions: Exercise Tolerance

Interventions: Other: placebo
Dietary Supplement: Oligomerized litchi fruit extract
Dietary Supplement: VItamin C + Vitamin E mixture

First Posted Date: 2008-08-11

Last Posted Date: 2008-08-12

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 69

Registration Number: NCT00731926

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy